Results 271 to 280 of about 31,218,454 (304)
Some of the next articles are maybe not open access.

Genetics of Type 2 diabetes

Diabetic Medicine, 2005
AbstractType 2 diabetes (T2D) has become a health‐care problem worldwide, with the rise in disease prevalence being all the more worrying as it not only affects the developed world but also developing nations with fewer resources to cope with yet another major disease burden. Furthermore, the problem is no longer restricted to the ageing population, as
openaire   +2 more sources

Testosterone and type 2 diabetes

Current Opinion in Endocrinology, Diabetes & Obesity, 2010
To describe the relationship between testosterone levels and type 2 diabetes (T2D).Multiple epidemiological studies have shown that low testosterone levels are associated with and predict the future development of T2D and the metabolic syndrome. Although this relationship is confounded by the association of total testosterone with sex hormone-binding ...
Mathis, Grossmann   +2 more
openaire   +2 more sources

Type 2 diabetes in youth

Biochemistry and Cell Biology, 2015
Since the 1990s, concerns about a global obesity epidemic have flourished. These concerns regarding obesity are expressed in popular culture and scientific literature and emphasize both weight and weight loss when defining health and well-being. As a result scholars are now calling attention to a “shadow epidemic” of weight stigma that is shown to ...
Erin, Cameron, Caitlin, O'Reilly
openaire   +2 more sources

Type 2 diabetes in children

Nursing Standard, 2001
The prevalence of type 2 diabetes mellitus is increasing in children and is reaching epidemic proportions in some western countries. Sue Howdle and Terry Wilkin examine the extent of the problem, the disease process, screening, prevention and management of type 2 diabetes.
S, Howdle, T, Wilkin
openaire   +2 more sources

Type 2 Diabetes

Annals of Internal Medicine, 2020
Shen, Tian   +4 more
openaire   +2 more sources

▼Liraglutide for type 2 diabetes?

Drug and Therapeutics Bulletin, 2010
Several drugs that act on the incretin hormonal system are now licensed in the UK as add-on therapy for patients with type 2 diabetes mellitus and inadequate glycaemic control.1 ▼Liraglutide (Victoza – Novo Nordisk) is a recently licensed long-acting glucagon-like peptide-1 (GLP-1) mimetic that can be given once daily as a subcutaneous injection, as ...
openaire   +2 more sources

Type 2 diabetes and pregnancy

Seminars in Fetal and Neonatal Medicine, 2005
Type 2 diabetes is a growing concern, with the number of new cases increasing and occurring at a younger age due to obesity. Consequently the number of cases arising in women of child-bearing age is increasing, and the condition will be encountered more frequently in the antenatal clinic. Type 2 diabetes is often perceived as a benign form of diabetes,
openaire   +2 more sources

The burden and risks of emerging complications of diabetes mellitus

Nature Reviews Endocrinology, 2022
Jonathan Shaw   +2 more
exaly  

Home - About - Disclaimer - Privacy